EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Shielding resources for four common radiopharmaceuticals utilized for imaging and therapy: Tc‐99m, F‐18, I‐131, and Lu‐177

Michael Oumano iD, Richard Wendt iD, James Botti, Nathan Busse, David Hintenlang, Stephanie Leon iD, Kevin Little iD, Melissa Martin, Richard Massoth, Kenneth Matthews iD, Rameshwar Prasad, Sharon White und 1 weitere

Journal of Applied Clinical Medical Physics · 2025

DOI: 10.1002/acm2.70084 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Applied Clinical Medical Physics, 2025. Verfasst von Michael Oumano und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Biological Sciences, Brown University, Providence, Rhode Island, USA. Hauptthemen laut MEDLINE: Radiopharmaceuticals, Radiation Protection, Technetium, Iodine Radioisotopes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The use of radioactive materials in the United States has been tightly regulated by the Nuclear Regulatory Commission and other entities for many decades. In 2015, however, the Joint Commission began to require hospital‐based nuclear medicine departments to conduct shielding designs and evaluations for radioactive material areas, mirroring established x‐ray practices. NCRP Report No. 147 guides diagnostic medical x‐ray shielding, but obviously cannot be used alone for nuclear medicine applications. The rising demand for theranostic nuclear medicine shielding evaluations particularly necessitates updated focused guidance, the aim of this report.

Methods

Monte Carlo simulations were conducted using GATE software to analyze the effects of various barriers on the transmission of radioactive emissions. The simulations used point sources of Tc‐99m, F‐18, I‐131, and Lu‐177 and evaluated dose deposition to blocks of tissue using Dose Actors. Different ceiling heights (ranging from 10–16 feet) were also tested for scattering effects. The Archer equation was employed to fit transmission curves and estimate required barrier thicknesses.

Results

Broad beam transmission factors and Archer fitting parameters are reported for various materials including lead, gypsum, concrete (light weight and normal weight), glass, and steel. A sample shielding calculation is provided for a wall separating Lu‐177 dotatate patients from an adjacent office to maintain public dose limits. Relevant occupancy factors are also provided.

Conclusions

While Lu‐177 has a relatively low exposure rate constant, shielding may be necessary for high‐volume therapies like Lu‐177 DOTATATE and Lu‐177 vipivotide tetraxetan PSMA. Shielding involves accounting for broad radiation beams and requires thorough characterization of radiation buildup. When shielding to the typical height of 7 feet, scatter from ceilings and floors is negligible for transmission above 10%, but severely limits the ability to shield for transmission below 1%.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RadiopharmaceuticalsRadiation ProtectionTechnetiumIodine RadioisotopesLutetiumRadioisotopesPhantoms, ImagingHumansMonte Carlo MethodFluorine Radioisotopes

Stichwörter der Autor:innen

Lu‐177nuclear medicineradiation safetyshieldingtheranostics

Substanzen

RadiopharmaceuticalsTechnetiumIodine RadioisotopesLutetiumRadioisotopesLutetium-177Iodine-131Fluorine Radioisotopes

Autor:innen und Institutionen

  • Department of Medicine and Biological Sciences, Brown University, Providence, Rhode Island, USA.
  • Department of Medical Physics and Radiation Safety, Rhode Island Hospital, Providence, Rhode Island, USA.
  • Landauer Medical Physics, Glenwood, Illinois, USA.
  • UT MD Anderson Cancer Center, Houston, Texas, USA.
  • Nuclear Medicine Medical Physics Consultants, Ann Arbor, Michigan, USA.
  • Colorado Associates in Medical Physics, Denver, Colorado, USA.

ORCID-Profile: Michael Oumano, Richard Wendt, Stephanie Leon, Kevin Little, Kenneth Matthews

Zitieren

APA

Oumano, M., Wendt, R., Botti, J., Busse, N., Hintenlang, D., Leon, S., Little, K., Martin, M., Massoth, R., Matthews, K., Prasad, R., White, S., & Clements, J. (2025). Shielding resources for four common radiopharmaceuticals utilized for imaging and therapy: Tc‐99m, F‐18, I‐131, and Lu‐177. Journal of Applied Clinical Medical Physics. https://doi.org/10.1002/acm2.70084

Vancouver

Oumano M, Wendt R, Botti J, Busse N, Hintenlang D, Leon S, et al. Shielding resources for four common radiopharmaceuticals utilized for imaging and therapy: Tc‐99m, F‐18, I‐131, and Lu‐177. Journal of Applied Clinical Medical Physics. 2025. doi:10.1002/acm2.70084

BibTeX
@article{Oumano2025,
  author = {Oumano, Michael and Wendt, Richard and Botti, James and Busse, Nathan and Hintenlang, David and Leon, Stephanie and Little, Kevin and Martin, Melissa and Massoth, Richard and Matthews, Kenneth and Prasad, Rameshwar and White, Sharon and Clements, Jessica},
  title = {Shielding resources for four common radiopharmaceuticals utilized for imaging and therapy: Tc‐99m, F‐18, I‐131, and Lu‐177},
  journal = {Journal of Applied Clinical Medical Physics},
  year = {2025},
  doi = {10.1002/acm2.70084}
}
Kostenlos starten →